The American Heart Association honored John Spertus, M.D., M.P.H., professor of medicine and Daniel J. Lauer, M.D., Chair in Metabolism and Vascular Disease Research, with the Outstanding Lifetime Achievement Award on Nov. 10. The award was given at the association’s 2015 Scientific Sessions in Orlando, Florida by the Council on Quality of Care and Outcomes Research (QCOR).
Spertus has focused on creating practices to measure a patient’s health care results and quality of care, and developing technology to help guide medical-decision making using models that measure and predict the risk factors of various procedures. The research led to his development of two tools — the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire — that many experts cite as the gold standards for measuring symptoms, function and quality of life in treating coronary artery disease and heart failure.
“John is one of the most creative and inspirational figures in the field of cardiovascular outcomes research,” said Benjamin Nallamouthu, M.D., M.P.H., award chair and associate professor of medicine at the University of Michigan. “He’s a giant in our field, a leader who played an instrumental role in establishing the QCOR conference and council.”
In 2013, Spertus received the QCOR council’s Distinguished Achievement Award for his efforts in cardiovascular treatment and outcomes research.
“Dr. Spertus has established himself as a trailblazer and renowned leader in the study of cardiovascular treatment and patient outcomes,” said School of Medicine Dean Steven Kanter, M.D. “This is wonderful, well-deserved honor. Dr. Spertus is a shining example of the outstanding leaders of medical research that we are privileged to have as members of our faculty at the School of Medicine.”
Spertus serves as the clinical director of outcomes research at the Saint Luke’s Hospital Mid America Heart Institute.
“The quest for improving patient care and outcomes has been John’s lifework,” said Melinda L. Estes, M.D., president and CEO of Saint Luke’s Health System. “His research has been at the forefront of the field of personalized medicine and the impact of his research cannot be overstated. This recognition by the American Heart Association is a tremendous honor and a testament to the pivotal role he has played in changing the face of medicine. Saint Luke’s Health System and Saint Luke’s Mid America Heart Institute are both extremely proud to have John leading our outcomes research team and congratulate him on this well-deserved honor.”